VPRIV® (velaglucerase alfa)
VPRIV® (velaglucerase alfa for injection) is a form of enzyme replacement therapy (ERT) that’s used for long-term treatment of pediatric and adult patients with Type 1 Gaucher disease — a gene mutation that causes a lack of glucocerebrosidase. When you don’t have enough of such enzymes, bones can erode, the liver and spleen can become enlarged, and the patient may experience muscle weakness and seizures.
Please refer to the full prescribing information.
Note: Please speak with your healthcare provider for more information if you think this therapy might be right for you.
How do I make a referral or transition my treatment to Infusion Associates?
1. Ask your healthcare provider to fax us a completed order form for your medication, clinical notes, demographics and your insurance card to (833) 996-4888.
2. Providers can find order forms on our medications page.
3. One of our intake specialists will contact your healthcare provider to confirm receipt of your referral.
4. We will then verify benefits, obtain any required prior authorizations, and contact you to schedule an appointment.